If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Software Group Regulatory News (APTD)

Share Price Information for Aptitude Software Group (APTD)

Share Price is delayed by 15 minutes
Get Live Data
198.00    -15.00 (-7.04%)
Bid:
196.50
Ask:
204.00
Spread: 7.50 (3.817%)
Market Cap: £105.97m
APTD Live PriceLast checked at - London Stock Exchange

Intraday Aptitude Software Group Share Chart

Board Transition

5 Feb 2025 07:01

RNS Number : 9187V
Aptitude Software Group PLC
05 February 2025
 

5 February 2025

Aptitude Software Group plc

("Aptitude", "the Group")

Board Transition

Aptitude (LSE:APTD), a market-leading provider of finance transformation software solutions, specialising in fully autonomous finance, today provides an update regarding a Board change.

The Aptitude organisation has been realigned to support the new product and business priorities, including the creation of a smaller, globally integrated senior management team with increased travel requirements and expanded spans of control. As a result, by mutual agreement, Mike Johns will step down from his role as CFO and from the Aptitude Board. Mike has agreed to remain in his role and as a Director of the Group to support the business, oversee the Full Year 2024 results and ensure an orderly transition. The search for his successor has commenced, and the Group will share further details in due course.

The Board would like to extend its thanks to Mike for his support of Aptitude over his seven years with the Group. In preparation for this transition, the financial and commercial functions have been strengthened while we appoint Mike's successor. A further update will be provided when Mike steps down from the Aptitude Board.

 

Aptitude Software Group plc

020-3687-3200

 

Alex Curran, Chief Executive Officer

Ivan Martin, Chairman

 

Mike Johns, Chief Financial Officer

 

 

 

Canaccord Genuity Limited

020-7523-8000

Simon Bridges / Andrew Potts

 

 

 

Alma Strategic Communications

 

Caroline Forde / Hilary Buchanan

020-3405-0205

 

 About Aptitude Software

Aptitude Software provides software solutions that deliver fully autonomous finance to enable its clients to drive growth, efficiency and sustainability. Fynapse is Aptitude's intelligent finance data management and accounting platform designed to increase productivity and lower costs for finance teams globally. Fynapse provides a single view of finance and business data, unparalleled performance and automation, faster and better insights, user-friendly functionality and market-leading total cost of ownership

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOASSUFALEISEIE
Date   Source Headline
29th Sep 20237:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
21st Sep 20232:28 pmRNSHolding(s) in Company
20th Sep 20239:32 amRNSHolding(s) in Company
7th Sep 202310:15 amRNSGrant of Awards under Performance Share Plan
23rd Aug 20231:21 pmRNSHolding(s) in Company
23rd Aug 20231:15 pmRNSHolding(s) in Company
28th Jul 202312:18 pmRNSHolding(s) in Company
28th Jul 20237:00 amRNSHolding(s) in Company
27th Jul 20231:52 pmRNSHolding(s) in Company
26th Jul 20237:00 amRNSInterim Results
24th Jul 20235:22 pmRNSHolding(s) in Company
20th Jul 20237:00 amRNSHolding(s) in Company
19th Jul 20237:00 amRNSDirector Retirement
13th Jul 20237:00 amRNSTrading Update and Directorate Changes
23rd Jun 20234:43 pmRNSHolding(s) in Company
16th Jun 20234:22 pmRNSHolding(s) in Company
25th May 20235:22 pmRNSDirector/PDMR Shareholding
24th May 202311:01 amRNSHolding(s) in Company
23rd May 20236:10 pmRNSDirector/PDMR Shareholding
23rd May 20233:27 pmRNSHolding(s) in Company
17th May 202311:24 amRNSResult of AGM
17th May 20237:00 amRNSAGM Statement and Appointment of CFO
2nd May 202311:44 amRNSHolding(s) in Company
24th Apr 20235:13 pmRNSExercise of awards under 2020 Deferred Bonus Plan
20th Apr 202311:30 amRNSGrant of awards under 2020 Deferred Bonus Plan
17th Apr 202311:49 amRNSHolding(s) in Company
17th Apr 20238:32 amRNSHolding(s) in Company
29th Mar 20234:36 pmRNSDirector/PDMR Shareholding
29th Mar 20234:35 pmRNSPrice Monitoring Extension
29th Mar 202311:27 amRNSBLOCK LISTING SIX MONTHLY RETURN
21st Mar 20237:00 amRNSAudited Results for Year Ended 31 December 2022
13th Feb 20235:20 pmRNSHolding(s) in Company
1st Feb 20234:40 pmRNSSecond Price Monitoring Extn
1st Feb 20234:35 pmRNSPrice Monitoring Extension
26th Jan 20237:00 amRNSHolding(s) in Company
24th Jan 20237:00 amRNSFull Year Trading Update and Directorate Change
12th Jan 20239:51 amRNSNew Directorship Notification
24th Nov 20227:00 amRNSGrant of awards under Performance Share Plan
8th Nov 20227:00 amRNSGrant of awards
21st Oct 20224:41 pmRNSSecond Price Monitoring Extn
21st Oct 20224:36 pmRNSPrice Monitoring Extension
28th Sep 20227:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
28th Jul 20227:00 amRNSInterim Results
18th Jul 20227:00 amRNSNotice of Results
31st May 202211:40 amRNSTotal Voting Rights
26th May 20228:56 amRNSHolding(s) in Company
17th May 20221:57 pmRNSDirector/PDMR Shareholding and Total Voting Rights
5th May 20222:10 pmRNSDirector Shareholding
29th Apr 202210:56 amRNSTotal Voting Rights
28th Apr 202212:24 pmRNSResult of AGM and Directorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.